Investing.com - U.S. pharmaceutical giant Pfizer reported weaker-than-expected first-quarter earnings, sending its shares lower in pre-market trade, it said on Tuesday.
Earlier in the day, in its first quarter earnings report, Pfizer said adjusted earnings per share came in at USD0.54, below expectations for USD0.55 per share.
The company’s first quarter revenue totaled USD13.5 billion, missing expectations for revenue of USD14 billion.
Pfizer said it expected full-year earnings to come in a range between USD2.14 to USD2.24 per shares, compared to a previous forecast of USD2.20 to USD2.30 per share.
Following the release of the report, shares in PFE fell 3% in pre-market trade.
The outlook for U.S. equity markets remained modestly lower. The Dow Jones Industrial Average futures indicated a loss of 0.1% at the open, S&P 500 futures pointed to a decline of 0.15% and Nasdaq 100 futures indicated a fall of 0.1%.
Earlier in the day, in its first quarter earnings report, Pfizer said adjusted earnings per share came in at USD0.54, below expectations for USD0.55 per share.
The company’s first quarter revenue totaled USD13.5 billion, missing expectations for revenue of USD14 billion.
Pfizer said it expected full-year earnings to come in a range between USD2.14 to USD2.24 per shares, compared to a previous forecast of USD2.20 to USD2.30 per share.
Following the release of the report, shares in PFE fell 3% in pre-market trade.
The outlook for U.S. equity markets remained modestly lower. The Dow Jones Industrial Average futures indicated a loss of 0.1% at the open, S&P 500 futures pointed to a decline of 0.15% and Nasdaq 100 futures indicated a fall of 0.1%.